Plasma Level of hsa-miR-619-5p microRNA Is Associated with Prostatic Cancer Dissemination beyond the Capsule.

Autor: Shkurnikov MY; BioClinicum Research Centre, Moscow, Russia. mshkurnikov@gmail.com.; P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia, Moscow, Russia. mshkurnikov@gmail.com., Makarova YA; BioClinicum Research Centre, Moscow, Russia., Knyazev EN; BioClinicum Research Centre, Moscow, Russia.; P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia, Moscow, Russia., Fomicheva KA; P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia, Moscow, Russia., Galatenko AV; BioClinicum Research Centre, Moscow, Russia., Nyushko KM; P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia, Moscow, Russia., Galatenko VV; BioClinicum Research Centre, Moscow, Russia., Vechorko VI; Federal Research Institute of Health Organization and Informatics, Ministry of Health of the Russian Federation, Moscow, Russia., Alekseev BY; P. A. Herzen Moscow Oncology Research Institute, Affiliated Branch of National Medical Research Radiology Center, Ministry of Health of Russia, Moscow, Russia.
Jazyk: angličtina
Zdroj: Bulletin of experimental biology and medicine [Bull Exp Biol Med] 2017 Aug; Vol. 163 (4), pp. 475-477. Date of Electronic Publication: 2017 Aug 29.
DOI: 10.1007/s10517-017-3831-x
Abstrakt: Profiles of circulating microRNA in the plasma of patients with prostate cancer with pathomorphological stages pT2, pT3, and pT4 are analyzed. The level of circulating microRNA hsa-miR-619-5p is elevated in patients with extracapsular spreading of the tumor, increasing significantly from stage pT2 to stage pT4.
Databáze: MEDLINE
Externí odkaz: